TBK1 and infection: A549 cells were pretreated with DMSO, MRT67307 HCl, a kinase inhibitor of TBK1 and IKKε, or Pyrrolidinedithiocarbamate ammonium, a selective NF-κB inhibitor, followed by BJ501 infection for 24 h.